Northwestern Mutual Wealth Management
RARE icon

Northwestern Mutual Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.62K Buy
459
+429
+1,430% +$9.66K ﹤0.01% 3082
2025
Q4 		$690 Hold
30
– – ﹤0.01% 3682
2025
Q3 		$902 Sell
30
-126
-81% -$3.78K ﹤0.01% 3571
2025
Q2 		$5.67K Buy
156
+103
+194% +$3.71K ﹤0.01% 2973
2025
Q1 		$1.92K Buy
+53
New +$2.21K ﹤0.01% 3164
2024
Q4 		– Sell
-22
Closed -$1.22K – 3834
2024
Q3 		$1.22K Buy
+22
New +$1.12K ﹤0.01% 3207
2024
Q1 		– Sell
-10
Closed -$478 – 3773
2023
Q4 		$478 Sell
10
-90
-90% -$3.49K ﹤0.01% 3281
2023
Q3 		$3.56K Buy
+100
New +$3.96K ﹤0.01% 2831
2023
Q2 		– Sell
-5
Closed -$201 – 3557
2023
Q1 		$201 Buy
+5
New +$215 ﹤0.01% 3185
2022
Q3 		– Sell
-60
Closed -$4K – 3341
2022
Q2 		$4K Buy
+60
New +$3.69K ﹤0.01% 2789
2022
Q1 		– Sell
-50
Closed -$4K – 3342
2021
Q4 		$4K Buy
+50
New +$4.07K ﹤0.01% 2851

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Northwestern Mutual Wealth Management's RARE Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Ultragenyx Pharmaceutical (RARE) stake by 1,430% in Q1 2026, buying an estimated $9.66K and bringing the position to 459 shares worth $9.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3082.

Northwestern Mutual Wealth Management first reported a position in RARE in Q4 2021 and has held it in 11 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Northwestern Mutual Wealth Management held 459 shares of Ultragenyx Pharmaceutical worth $9.62K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 429 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $9.66K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3082 holding.
  • Northwestern Mutual Wealth Management first reported a position in Ultragenyx Pharmaceutical in Q4 2021 and has held it in 11 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.